Search Results - "Krisl, Jill C."

  • Showing 1 - 11 results of 11
Refine Results
  1. 1

    Gastrointestinal Bleeding in Left Ventricular Assist Device: Octreotide and Other Treatment Modalities by Molina, Tara L, Krisl, Jill C, Donahue, Kevin R, Varnado, Sara

    Published in ASAIO journal (1992) (01-07-2018)
    “…Left ventricular assist devices (LVADs) offer a therapeutic strategy for patients with end-stage heart failure. Increased device utilization has also increased…”
    Get full text
    Journal Article
  2. 2

    Leflunomide Efficacy and Pharmacodynamics for the Treatment of BK Viral Infection by Krisl, Jill C, Taber, David J, Pilch, Nicole, Chavin, Kenneth, Bratton, Charles, Thomas, Beje, McGillicuddy, John, Baliga, Prabhakar

    “…BK virus is an infection in kidney transplantation patients jeopardizing graft survival. Unfortunately, there is no consensus on treatment of BK viremia and…”
    Get full text
    Journal Article
  3. 3

    Terbutaline for Management of Relative Bradycardia Post‐Orthotopic Heart Transplant: A Single Center Experience by Tu, Zoe H., Yun, Allison N., Gorthi, Janardhana, Guha, Ashrith, Krisl, Jill C., Bhimaraj, Arvind

    Published in Clinical transplantation (01-11-2024)
    “…ABSTRACT Background Vagal nerve denervation during the heart transplant procedure results in higher resting heart rates in these recipients compared to the…”
    Get full text
    Journal Article
  4. 4

    Role of thromboelastography in predicting and defining pump thrombosis in left ventricular assist device patients by Xia, Ranran, Varnado, Sara, Graviss, Edward A., Nguyen, Duc T., Cruz-Solbes, Ana, Guha, Ashrith, Krisl, Jill C.

    Published in Thrombosis research (01-08-2020)
    “…Optimal anticoagulation for left ventricular assist device recipients aims to balance thrombosis and bleeding complications. Routine plasma-based coagulation…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Acute Rejection Clinically Defined Phenotypes Correlate With Long-term Renal Allograft Survival by Krisl, Jill C, Alloway, Rita R, Shield, Adele Rike, Govil, Amit, Mogilishetty, Gautham, Cardi, Michael, Diwan, Tayyab, Abu Jawdeh, Bassam G, Girnita, Alin, Witte, David, Woodle, E Steve

    Published in Transplantation (01-10-2015)
    “…BACKGROUNDClassification of acute rejection (AR) based on etiology and timing may provide a means for enhancing therapeutic results and allograft survival…”
    Get full text
    Journal Article
  7. 7

    A Case-Based Approach to the Practical Application of Dexmedetomidine in Critically Ill Adults by MacLaren, Robert, Krisl, Jill C., Cochrane, Rebecca E., Mueller, Scott W.

    Published in Pharmacotherapy (01-02-2013)
    “…Dexmedetomidine is a selective α2‐adrenoceptor agonist that offers unique sedation because patients are readily awakened while administration continues and the…”
    Get full text
    Journal Article
  8. 8

    Clinical Usefulness of Recombinant Activated Factor VII in Patients with Liver Failure Undergoing Invasive Procedures by Krisl, Jill C, Meadows, Holly E, Greenberg, Charles S, Mazur, Joseph E

    Published in The Annals of pharmacotherapy (01-11-2011)
    “…Objective: To evaluate the use of recombinant activated factor VII (rFVIIa) in patients with liver failure undergoing invasive procedures. Methods: An…”
    Get full text
    Journal Article
  9. 9
  10. 10

    The Use of Activated Recombinant Factor VII in a Patient with Fulminant Hepatic Failure Requiring Placement of an Intracranial Pressure Monitor by Meadows, Holly B, Krisl, Jill C, Greenberg, Charles S, Mazur, Joseph E

    Published in The Annals of pharmacotherapy (01-11-2011)
    “…Objective: To evaluate the use of recombinant activated factor VII (rFVIIa) in a patient with fulminant hepatic failure (FHF) requiring placement of an…”
    Get full text
    Journal Article
  11. 11